Abstract
Nutrition and health are closely connected and malnutrition can seriously endanger health. The consequences are higher risks of developing diseases. Of these, cancers are of special importance. The most frequent nutrition-associated type of cancer is colon cancer. This review summarises the predisposing factors for the development of colon cancer, and molecular mechanisms responsible for sporadic colon cancer. Moreover, it is pointed out that individual genetic predisposition such as polymorphisms of biotransformation systems might affect susceptibility to cancer risk factors. Selected findings of epidemiological research and nutritional habits, foods, and metabolites that could increase cancer risk are discussed. Furthermore, toxicological assessment of food-related risk factors, e.g. heterocyclic amines, and potential protective effects of food ingredients, e.g. the induction of phase II enzymes or removal of already degenerated cells from tissue by apoptosis, inhibition of proliferation, and cell differentiation are discussed. Risks are not necessarily reduced by avoiding certain substances but by healthy and well-balanced nutrition. Knowledge of individual susceptibility will also make it possible to recognise risks and design more specific nutritional recommendations.
Similar content being viewed by others
References
German Institute for Nutrition, Potsdam-Rehbrücke, and World Cancer Research Fund (1999) (ed) Krebsprävention durch Ernährung
World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington DC
Fodde R, Smits R, Clevers H (2001) Nat Rev Cancer 1:55–67
Kinzler KW, Vogelstein B (1996) Cell 87:159–170
Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y (1998) N Engl J Med 339:1277–1284
Hawkins NJ, Ward RL (2001) J Natl Cancer I 93:1307–1313
Rowland IR, Mallett AK, Wise A (1985) Crit Rev Toxicol 16:31–103
Cummings JH, Englyst HN (1987) Am J Clin Nutr 45:1243–1255
Hill MJ (1995) Eur J Cancer Prev 4:353–358
Hylemon PB, Glass TL (1983) Biotransformation of bile acids and cholesterol by the intestinal microflora. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, New York, pp 189–213
Owen RW (1986) The metabolism of bile acids. In: Hill MJ (ed) Microbial metabolism in the digestive tract. CRC Press, Boca Raton, pp 51–65
Reddy BS (1981) Cancer Res 41:3766–3768
Slattery ML, Benson J, Berry TD, Duncan D, Edwards SL, Caan BJ, Potter JD (1997) Cancer Epidemiol Biomarkers Prev 6:677–685
Boutron-Ruault MC, Senesse P, Méance S, Belghiti C, Faivre J (2001) Nutr Cancer 39:50–57
Rieger MA, Parlesak A, Pool-Zobel BL, Rechkemmer G, Bode C (1999) Carcinogenesis 20:2317–2326
Bardou M, Montembault S, Giraud V, Balian A, Borotta E, Houdayer C, Capron F, Chaput JC, Naveau S (2002) Gut 50:38–42
Erhardt JG, Lim SS, Bode JC, Bode C (1997) J Nutr 127:706–709
Nagata C, Kodama M, Ioki Y, Kimura T (1982) In: Floyd RA (ed) Free radicals and cancer. Marcel Dekker, New York, NY
Owen RW, Spiegelhalder B, Bartsch H (2000) Gut 46:225–232
Dittberner U, Eisenbrand G, Zankl H (1995) Mutat Res 335:259–265
Esterbauer H, Eckl P, Ortner A (1990) Mutat Res 238:223–233
Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M (1997) Carcinogenesis 18:1739–1743
Kim YI (1999) J Nutr Biochem 10:66–88
Selker EU (1999) Cell 97:157–160
Bingham SA, Pignatelli B, Pollock JRA, Ellul A, Malaveille C, Gross G, Runswick S, Cummings JH, O’Neill IKO (1996) Carcinogenesis 17:515–523
Reistad R, Rossland OJ, Latva-Kala KJ, Rasmussen T, Vikse R, Becher G, Alexander J (1998) Food Chem Toxicol 35:945–955
Eisenbrand G, Tang W (1993) Toxicology 84:1–82
Johansson G, Holmén A, Persson L, Bögstedt B, Wassén C, Ottova L, Gustafsson JA (1992) Carcinogenesis 13:153–157
IARC (1994) Monographs on the evaluation of carcinogen risk to humans: some industrial chemicals No 60. Lyon: International Agency for Research on Cancer
Mottram DS, Wedzicha BL, Dodson AT (2002) Nature 419(6906):448–449
Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW (1986) Toxicol Appl Pharmacol 85:154–168
Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K (2003) Br J Cancer 88:84–89
Schettgen T, Weiss T, Drexler H, Angerer J (2003) Int J Hyg Environ Health 206:9–14
Rafter J, Child P, Anderson AM, Alder R, Eng V, Bruce WR (1987) Am J Clin Nutr 45:559–563
Venturi M, Hambly RJ, Glinghammer B, Rafter JJ, Rowland IR (1997) Carcinogenesis 18:2353–2359
Glinghammar B, Holmberg K, Rafter J (1999) Carcinogenesis 20:969–976
Potter JD (1999) J Natl Cancer I 91:916–932
Bach SP, Renehan AG, Potten CS (2000) Carcinogenesis 21:469–476
Manus B, Adang RP, Ambergen AW, Brägelmann R, Armbrecht U, Stockbrügger RW (1997) Eur J Cancer Prev 6:38–43
Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Willett WC (1992) J Natl Cancer I 84:91–98
Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR (1999) Proc Natl Acad Sci USA 96:15121–15126
Felton JS, Knize MG, Roper M, Fultz E, Shen NH, Turteltaub KW (1992) Cancer Res 52:2103–2107
Sinha R, Rothman N, Brown ED, Mark SD, Hoover RN, Caporaso NE, Levander OA, Knize MG, Lang NP, Kadlubar FF (1994) Cancer Res 54:6154–6159
Pool-Zobel BL, Leucht U (1997) Mutat Res 375:105–116
Gooderham NJ (1997) ECP-News 31:24–26
Malfatti MA, Felton JS (2001) Carcinogenesis 22:1087–1093
Wakabayashi K, Nagao M, Esumi H, Sugimura T (1992) Cancer Res 52(Suppl):2092–2098
Nakagama H, Ochiai M, Ubagai T, Tajima R, Fujiwara K, Sugimura T, Nagao M (2002) Mutat Res 506/507:137–144
Ubagai T, Ochiai M, Kawamori T, Imai H, Sugimura T, Nagao M, Nakagama H (2002) Carcinogenesis 23:197–200
Kristiansen E, Meyer O, Thorup I (1997) Eur J Cancer Prev 6:53–57
Wargovich MJ, Harris C, Chen CD, Palmer C, Steele VE, Kelloff GJ (1992) J Cell Biochem Suppl 16G:51–54
Moller P, Wallin H, Vogel U, Autrup H, Risom L, Hald MT, Daneshvar B, Dragsted LO, Poulsen HE, Loft S (2002) Carcinogenesis 23:1379–1385
Kristiansen E, Meyer O, Thorup I (1996) Cancer Lett 105:147–151
Kristiansen E, Thorup I, Meyer O (1995) Nutr Cancer 23:151–159
Luceri C, Caderni G, Lancioni L, Aiolli S, Dolara P, Mastrandrea V, Scardazza F, Morozzi G (1996) Nutr Cancer 25:187–196
Dragsted LO, Daneshvar B, Vogel U, Autrup HN, Wallin H, Risom L, Moller P, Molck AM, Hansen M, Poulsen HE, Loft S (1993) Cancer Res 62:4339–4345
Corpet DE, Pirot V, Goubet I (1993) Cancer Lett 74:183–187
Xu M, Dashwood RH (1999) Cancer Lett 143:179–183
Santana-Rios G, Orner GA, Xu M, Izquierdo-Pulido M, Dashwood RH (2001) Nutr Cancer 41:98–103
Hagiwara A, Yoshino H, Ichihara T, Kawabe M, Tamano S, Aoki H, Koda T, Nakamura M, Imaida K, Ito N, Shirai T (2002) J Toxicol Sci 27:57–68
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF (1994) Cancer Res 54:4920–4926
Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF (1991) Carcinogenesis 12:1839–1845
LeMarchand L, Hankin JH, Wilkens LR, Pierce LM, Franke A, Kolonel LN, Seifried A, Custer LJ, Chang W, Lum-Jones A, Donlon T (2001) Cancer Epidemiol Biomarkers Prev 10:1259–1266
de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, de Vries EG, Sijmons RH, Hofstra RM, Kleibeuker JH (2002) Cancer Epidemiol Biomarkers Prev 11:1332–1352
Bartsch H, Nair J (2002) Cancer Detect Prev 26:308–312
Bartsch H (1999) IARC Sci Publ 150:1–16
Referenzwerte für die Nährstoffzufuhr, DGE. Umschau/Braus Verlag, Frankfurt/M 2000
Priebe MG, Vonk RJ, Sun X, He T, Harmsen HJ, Welling GW (2002) Eur J Nutr 41(Suppl 1):I2–I10
Takayama K, Yamashita K, Wakabayashi K, Sugimura T, Nagao M (1989) Jpn J Cancer Res 80:1145–1148
Takahashi S, Ogawa K, Ohshima H, Esumi H, Ito N, Sugimura T (1991) Jpn J Cancer Res 82:135–137
Ochiai M, Ogawa K, Wakabayashi K, Sugimura T, Nagase S, Esumi H, Nagao M (1991) Jpn J Cancer Res 82:363–266
Langouet S, Paehler A, Welti DH, Kerriguy N, Guillouzo A, Turesky RJ (2002) Carcinogenesis 23:115–122
Rohrmann S, Becker TW (2001) Die Aufnahme Heterozyklischer Aromatischer Amine in Deutschland Ergebnisse Einer Pilotstudie. In: EPIC Heidelberg Ernährungsumschau 2001:48
O’Dwyer PJ, Clayton M, Halbherr T, Myers CB, Yao K (1997) Clin Cancer Res 5:783–791
Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD (2001) Nutr Cancer 39:170–175
Borugian MJ, Sheps SB, Whittemore AS, Wu AH, Potter JD, Gallagher RP (2002) Cancer Epidemiol Biomarkers Prev 11:187–193
Ferguson LR, Harris PJ (2003) Lancet 361:1487–1488
Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D, Virtamo J (1999) Cancer Causes Control 10:387–396
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC (1999) N Engl J Med 340:169–176
Mai V, Flood A, Peters U, Lacey JV Jr, Schairer C, Schatzkin A (2003) Int J Epidemiol 32:234–239
McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V, Cohen LB, Pappas SC, Saibil FG (1994) J Clin Epidemiol 47:525–536
Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE (2000) N Engl J Med 342:1156–1162
Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J (2000) N Engl J Med 342:1149–1155
Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J (2000) Lancet 356:1300–1306
Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriguez JM, Alberts DS, Martinez ME (2002) J Natl Cancer Inst 94:1620–1625
Asano T, McLeod RS (2002) Cochrane Database Syst Rev (2)
Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjonneland A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E (2003) Lancet 361:1496–1501
Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB (2003) Lancet 361:1491–1495
Slavin JL, Martini MC, Jacobs DR Jr, Marquart L (1999) Am J Clin Nutr 70(3 Suppl):459S–463S
Pedersen A, Johansen C, Gronbaek M (2003) Gut 52:861–867
Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S (2003) Br J Cancer 88:1038–1043
Bardou M, Montembault S, Giraud V, Balian A, Borotto E, Houdayer C, Capron F, Chaput JC, Naveau S (2002) Gut.50:38–42
Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL (2002) J Natl Cancer Inst 94:437–446
Ames BN, Wakimoto P (2002) Nat Rev Cancer 2:694–704
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berlau, J., Glei, M. & Pool-Zobel, B.L. Colon cancer risk factors from nutrition. Anal Bioanal Chem 378, 737–743 (2004). https://doi.org/10.1007/s00216-003-2284-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-003-2284-4